UPDATE — Abeona Therapeutics(R) and Lurie Children’s Open First Center for ZEVASKYN(TM) Gene Therapy to Treat Wounds in Painful Skin Disorder

(NASDAQ:ABEO), – ZEVASKYN, the first and only cell-based gene therapy for patients with recessive dystrophic epidermolysis bullosa (RDEB), now commercially available in the U.S. – – Ann & Robert H. Lurie Children's Hospital of Chicago, a top-ranked hospital, is ready to evaluate patients for ZEVASKYN treatment – – Abeona Assist(TM) comprehensive patient services program in […]

UPDATE — Abeona Therapeutics(R) and Lurie Children’s Open First Center for ZEVASKYN(TM) Gene Therapy to Treat Wounds in Painful Skin Disorder

UPDATE — Abeona Therapeutics(R) and Lurie Children's Open First Center for ZEVASKYN(TM) Gene Therapy to Treat Wounds in Painful Skin Disorder GlobeNewswire May 14, 2025 – ZEVASKYN, the first and only cell-based gene therapy for patients with recessive dystrophic epidermolysis bullosa (RDEB), now commercially available in the U.S. – – Ann & Robert H. Lurie

IO Biotech Reports First Quarter 2025 Financial Results and Business Highlights

(NASDAQ:IOBT), Primary endpoint of pivotal Phase 3 trial (IOB-013/KN-D18) of lead investigational therapeutic cancer vaccine in patients with advanced melanoma still expected to readout in third quarter of 2025 Data presented at recent congresses reinforces the potential of the company's T-Win candidates to reshape the tumor microenvironment and drive more effective anti-tumor responses Company recognized

Presage Global Named Top “Security Consulting & Risk Management” Firm at 2025 Family Wealth Report Awards

Presage Global, an intelligence-powered risk management and advisory firm serving high-net-worth families, global enterprises, and institutional investors, has won the “Security Consulting & Risk Management” category at the prestigious Twelfth Annual Family Wealth Report Awards, held in New York City. https://mma.prnewswire.com/media/2584290/Presage_Global.jpg Presage Global Named Top “Security Consulting & Risk Management” Firm at 2025 Family Wealth

Stark Future Achieves Record Profitability for All-Electric Motorcycle Manufacturer

Stark Future Sets New Sales and Operations Records of €18.3M Revenue and €2.8M Positive EBITDA in Breakthrough Month of April 2025. Stark Future, the global leader in high-performance electric motorcycles, has achieved a historic milestone by recording its highest-ever monthly revenue of €18.3 million while delivering a positive EBITDA of €2.8 million. This noteworthy result

Strolid Expands Executive Team to Accelerate Growth: Michael Donovan Named Vice President of Marketing

New leadership appointment positions Strolid to strengthen BDC growth and drive industry adoption of vCon conversational intelligence solutions. Strolid Inc., a pioneering tech-enabled automotive service company, today announced the appointment of Michael Donovan as Vice President of Marketing. This key addition to Strolid's executive leadership team underscores its commitment to accelerating growth across its established

Vintage Investment Partners Deepens its Commitment to European Venture Capital with the Appointment of Leyla Holterud as Partner and the Opening of an Office in London

Vintage Investment Partners (“Vintage”), a global venture capital platform with $4.3billion in AUM and founded in 2003, today announced the opening of its first European office in London and the appointment of LeylaHolterud as Partner to lead Vintage's further expansion across the region. https://mma.prnewswire.com/media/2686583/Vintage_Investment_Partners_Leyla_Holterud.jpg Vintage has been actively investing in Europe for over a decade,

New Hampshire Insurance Department Selects PSI Services as New Test Delivery Partner

PSI Services, a global leader in licensure testing, is proud to announce its selection by the New Hampshire Insurance Department (NHID) as their new vendor for administering insurance licensing examinations in the state. From July 1, 2025, PSI will offer exams for insurance producers, adjusters, and public adjusters, providing candidates with flexible testing options to

IO Biotech Reports First Quarter 2025 Financial Results and Business Highlights

IO Biotech Reports First Quarter 2025 Financial Results and Business Highlights GlobeNewswire May 14, 2025 Primary endpoint of pivotal Phase 3 trial (IOB-013/KN-D18) of lead investigational therapeutic cancer vaccine in patients with advanced melanoma still expected to readout in third quarter of 2025 Data presented at recent congresses reinforces the potential of the company's T-Win

The Institute for Financial Integrity and Crowell & Moring Expand Global Sanctions and Export Controls Training Program

For the past two years, the Institute for Financial Integrity (IFI) and international law firm Crowell & Moring have partnered on the global delivery of a training program aimed at promoting understanding of sanctions and strategic trade controls. The high-impact training program-already delivered in 18 countries, has officially been expanded to over 10 countries this

Scroll to Top